Mallinckrodt settles U.S. opioid drug probe for $35 million

Jul 11, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

(Reuters) – Mallinckrodt Plc , one of the largest manufacturers of the generic opioid painkiller oxycodone, will pay $35 million to resolve allegations that the company failed to report suspicious drug orders, the U.S. Justice Department said on Tuesday.